+1,248.5%
MRNA vs CVE
+303.7%
+944.9%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | CVE | Excess | Alpha |
|---|---|---|---|---|
| 1D | -6.8% | +0.3% | -7.0% | -6.8% |
| 7D | +9.8% | -10.0% | +19.8% | +10.6% |
| 30D | +11.5% | -11.9% | +23.3% | +12.4% |
| 3M | +319.4% | -5.9% | +325.3% | +319.8% |
| 6M | +361.5% | -1.6% | +363.1% | +358.9% |
| YTD | +750.6% | +66.3% | +684.3% | +702.2% |
| 1Y | +913.0% | +57.5% | +855.5% | +860.1% |
| 3Y | +258.1% | +65.4% | +192.6% | +234.8% |
| 5Y | +9.6% | +144.2% | -134.6% | -0.5% |
| All | +1,248.5% | +303.7% | +944.9% | +1,036.6% |
Cumulative growth
Daily Returns
Daily percentage return beside CVE.
Daily Out/Under-Performance
Portfolio return minus CVE return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CVE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded CVE wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling